Tuesday, March 02, 2021, 17.51
COVID-19 vaccine Where Thai people take the first step in self-reliance
Although the COVID-19 vaccine Developed by Thai people is still in the experimental stage. While vaccines from many manufacturers are already on the market. But this effort is not in vain as it is a stepping stone to self-reliance. And is a test of readiness to cope with other pandemic diseases That may come in the future It is also an opportunity to push research into the industry as well.
The National Research Agency (NRCT) has funded a research grant for the 2019 coronavirus vaccine, or COVID-19, to the National Vaccine Institute. Assigned Vaccine Research Center Faculty of Medicine Chulalongkorn University ChulaCov19 Vaccine Development and Prof. Kiatrak Rungtham Executive Director of the Covid-19 Vaccine Development Program And the vaccine is also supported by Second century capital Chulalongkorn University And a donation from the Chulalongkorn Medical Alumni Association Vaccine Research Donation Fund of Thai Red Cross Society
The ChulaCov19 vaccine is a mRNA vaccine made up of the genetic material of the COVID-19 virus. When injected into the body, the body produces proteins that are the nodules of the virus. And stimulate the body to build immunity against the virus when exposed to the virus After the mRNA vaccine is stimulated to make the protein, the mRNA fragment is broken down in a few days. This vaccine production technology has already been approved for emergency use in many countries. And there have been injections of more than 140 million doses of people around the world.
The ChulaCov19 vaccine is now being tested in a second dose in monkeys. It was found that monkeys were able to build high levels of immunity and were healthy. And from test results in special mice infected with COVID-19 It was found that the ChulaCov19 vaccine was able to protect 100% of mice from disease and 100% of the germs from entering the bloodstream, as well as reducing the number of infectious agents introduced into the nostrils of lab rats and lungs by more than 10,000,000. Only after that it will continue to enter human volunteer trials around the end of April to the beginning of May.
Despite the success of the COVID-19 vaccine Thai people will succeed later than many foreign vaccine manufacturers. Commented that This research is an important step for Thailand to be able to produce vaccines every step of the way. Unlike in the past, research was only intended to be published. But for this research, the vaccine also aims to drive industrial production.
–
